SAN FRANCISCO (Reuters) - A trial in which a California man alleged his use of Bayer AG's glyphosate-based Roundup weed killer caused his cancer went to a federal U.S. jury after lawyers for both ...

Cancer victims argue the proposed $7.25 billion Roundup "sweetheart deal" benefits Bayer and lawyers more than those harmed by the herbicide.

Opponents of Bayer AG’s $7.25 billion proposal in Missouri state court to settle thousands of US cancer lawsuits over its Roundup weedkiller are trying to get a federal judge in California who shares ...

A Pennsylvania judge on Tuesday drastically reduced a $2.25 billion verdict against Bayer AG (OTC:BAYRY), cutting it down to $400 million in a case involving a man who claimed he developed cancer from ...

ST. LOUIS (Reuters) - Bayer AG, facing an upcoming trial in St. Louis over allegations that its Roundup weed killer causes cancer, has recruited Missouri-based expert witnesses to make its case in a ...

Shares of Bayer BAYRY gained 12.1% after the Solicitor General supported a Supreme Court review of its Roundup weedkiller case in the United States. Bayer believes that the backing of the government ...

FRANKFURT, Germany - Shares in German farm chemicals, materials and drug company Bayer have plunged in the wake of a U.S. court verdict against Monsanto, which Bayer has acquired. Shares of Leverkusen ...

Bayer-owned agriculture firm Monsanto was ordered to pay $289 million to a groundskeeper who alleged that the ingredients of ...

Bayer’s Monsanto agricultural business has proposed a $7.25 billion settlement to resolve thousands of lawsuits linking Roundup weedkiller to cancer. The German multinational announced the resolution ...

SAN FRANCISCO/NEW YORK - A U.S. jury on Wednesday awarded $80 million to a man who claimed his use of Bayer AG's glyphosate-based weed killer Roundup caused his cancer, in the latest legal setback for ...